The Perceived Value of Pharmacogenetic Testing in Depression Treatment: Mixed-Methods Results From the PRIME Care Study
Overall, this mixed-methods study demonstrated that, after using PGx testing during a clinical trial, primary care and mental health providers have overall positive perceptions of its potential value and utility in depression treatment.
Authors
- Joseph A. Simonetti (ORCID: https://orcid.org/0000-0002-1092-160X)
- Kevin G. Lynch (ORCID: https://orcid.org/0000-0002-0426-0323)
- Laura O. Wray
- Leland E. Hull (ORCID: https://orcid.org/0000-0002-5736-6543)
- Sara R. Chapman
- Bonnie M. Vest (ORCID: https://orcid.org/0000-0002-3401-7367)
- David W. Oslin (ORCID: https://orcid.org/0000-0003-4392-4599)
- Michael E. Thase
- Christine M. Ramsey
Institutions
- VA Western New York Healthcare System (US)
Publication Details
- Journal
- Psychiatric Services
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1176/appi.ps.20240080
- Citations
- 1
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.56